V3-substanceAdminSubstitution.xml

Identifies what sort of change is permitted or has occurred between the therapy that was ordered and the therapy that was/will be provided.

<?xml version="1.0" encoding="UTF-8"?>

<ValueSet xmlns="http://hl7.org/fhir">
  <id value="v3-substanceAdminSubstitution"/> 
  <meta> 
    <lastUpdated value="2019-07-31T00:00:00.000+10:00"/> 
    <profile value="http://hl7.org/fhir/StructureDefinition/shareablevalueset"/> 
  </meta> 
  <text> 
    <status value="generated"/> 
    <div xmlns="http://www.w3.org/1999/xhtml">
      <p> Release Date: 2019-07-31</p> 

      <table class="grid">
 
        <tr> 
          <td> 
            <b> Level</b> 
          </td> 
          <td> 
            <b> Code</b> 
          </td> 
          <td> 
            <b> Display</b> 
          </td> 
          <td> 
            <b> Definition</b> 
          </td> 
        </tr> 
 
        <tr> 
          <td> 1</td> 
          <td> 
            <span style="color: grey">
              <i> (_ActSubstanceAdminSubstitutionCode)</i> 
            </span>  
            <b> 
              <i> Abstract</i> 
            </b> 
          </td> 
          <td> 
            <a name="v3-substanceAdminSubstitution-_ActSubstanceAdminSubstitutionCode"> </a> 
          </td> 
          <td> 
                        
                           Description: Substitution occurred or is permitted with another
               product that may potentially have different ingredients, but having the same biological
               and therapeutic effects.
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 2</td> 
          <td>   E
            <a name="v3-substanceAdminSubstitution-E"> </a> 
          </td> 
          <td> equivalent</td> 
          <td> 
                        
                           Description: Substitution occurred or is permitted with another
               bioequivalent and therapeutically equivalent product.
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 3</td> 
          <td>     EC
            <a name="v3-substanceAdminSubstitution-EC"> </a> 
          </td> 
          <td> equivalent composition</td> 
          <td> 
                        
                           Description: 
                        
            <br/>  

                        Substitution occurred or is permitted with another product that
               is a:
            <br/>  

                        
                           pharmaceutical alternative containing the same active ingredient
               but is formulated with different salt, ester
                           pharmaceutical equivalent that has the same active ingredient,
               strength, dosage form and route of administration
                        
                        
                           Examples: 
                        
            <br/>  

                        
                           
                              Pharmaceutical alternative: Erythromycin Ethylsuccinate
               for Erythromycin Stearate
                           
                              Pharmaceutical equivalent: Lisonpril for Zestril
                        
                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 4</td> 
          <td>       BC
            <a name="v3-substanceAdminSubstitution-BC"> </a> 
          </td> 
          <td> brand composition</td> 
          <td> 
                        
                           Description: 
                        
            <br/>  

                        Substitution occurred or is permitted between equivalent Brands
               but not Generics
            <br/>  

                        
                           Examples: 
                        
            <br/>  

                        
                           Zestril  for Prinivil
                           Coumadin for Jantoven
                        
                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 4</td> 
          <td>       G
            <a name="v3-substanceAdminSubstitution-G"> </a> 
          </td> 
          <td> generic composition</td> 
          <td> 
                        
                           Description: Substitution occurred or is permitted between
               equivalent Generics but not Brands
            <br/>  

                        
                           Examples: 
                        
            <br/>  

                        
                           Lisnopril (Lupin Corp) for Lisnopril (Wockhardt Corp)
                        
                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 3</td> 
          <td>     TE
            <a name="v3-substanceAdminSubstitution-TE"> </a> 
          </td> 
          <td> therapeutic alternative</td> 
          <td> 
                        
                           Description: Substitution occurred or is permitted with another
               product having the same therapeutic objective and safety profile.
            <br/>  

                        
                           Examples: 
                        
            <br/>  

                        
                           ranitidine for Tagamet
                        
                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 4</td> 
          <td>       TB
            <a name="v3-substanceAdminSubstitution-TB"> </a> 
          </td> 
          <td> therapeutic brand</td> 
          <td> 
                        
                           Description: Substitution occurred or is permitted between
               therapeutically equivalent Brands but not Generics
            <br/>  
&gt;
                           Examples: 
                        
            <br/>  

                        
                           Zantac for Tagamet
                        
                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 4</td> 
          <td>       TG
            <a name="v3-substanceAdminSubstitution-TG"> </a> 
          </td> 
          <td> therapeutic generic</td> 
          <td> 
                        
                           Description: Substitution occurred or is permitted between
               therapeutically equivalent Generics but not Brands
            <br/>  
&gt;
                           Examples: 
                        
            <br/>  

                        
                           Ranitidine  for cimetidine
                        
                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 2</td> 
          <td>   F
            <a name="v3-substanceAdminSubstitution-F"> </a> 
          </td> 
          <td> formulary</td> 
          <td> 
                        
                           Description: This substitution was performed or is permitted
               based on formulary guidelines. 
            <br/>  

                     
          </td> 
        </tr> 
 
        <tr> 
          <td> 2</td> 
          <td>   N
            <a name="v3-substanceAdminSubstitution-N"> </a> 
          </td> 
          <td> none</td> 
          <td> 
                        No substitution occurred or is permitted.
            <br/>  

                     
          </td> 
        </tr> 

      </table> 

    </div> 
  </text> 
  <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status">
    <valueCode value="external"/> 
  </extension> 
  <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm">
    <valueInteger value="0"/> 
  </extension> 
  <extension url="http://hl7.org/fhir/StructureDefinition/structuredefinition-wg">
    <valueCode value="vocab"/> 
  </extension> 
  <url value="http://terminology.hl7.org/ValueSet/v3-substanceAdminSubstitution"/> 
  <version value="2019-07-31"/> 
  <name value="v3.substanceAdminSubstitution"/> 
  <title value="v3 Code System substanceAdminSubstitution"/> 
  <status value="active"/> 
  <experimental value="false"/> 
  <date value="2019-07-31"/> 
  <publisher value="HL7, Inc"/> 
  <contact> 
    <telecom> 
      <system value="url"/> 
      <value value="http://hl7.org"/> 
    </telecom> 
  </contact> 
  <description value=" Identifies what sort of change is permitted or has occurred between the therapy that
     was ordered and the therapy that was/will be provided."/> 
  <immutable value="true"/> 
  <compose> 
    <include> 
      <system value="http://terminology.hl7.org/CodeSystem/v3-substanceAdminSubstitution"/> 
    </include> 
  </compose> 
</ValueSet>